The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...

The FDA granted orphan drug designation to amezalpat in hepatocellular carcinoma based on phase 1b/2 data showing efficacy ...

Years before Jim Porter got his current job — back when the president of the Pro Football Hall of Fame was still a 400-pound man who wore purple suits and Porter was selling newspapers, not appearing ...

Janux Therapeutics has a robust balance sheet, with $658.1 million in liquid assets and no debt. See why I reiterate my buy ...

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty ...

Ohio Republican leaders are looking at cutting spending for public education, calling the current formula "unsustainable." ...

As the current bull run occurs, the opportunities for capitalizing on investments do not end with the crypto market. The … ...

The northern Delaware park is replacing the historic Chambers House Nature Center with a center that focuses on education and ...

Enliven's initial phase 1 data for ELVN-001 in CML shows promising tolerability and activity in heavily pretreated patients. But read why ELVN stock is a Sell.

During its Oct. 7, 2023, attack on southern Israel, Hamas and other groups killed some 1,200 people and took about 250 ...

Utah Legislature will be tackling a wide range of issues when their general session begins Jan. 21 — ...